Background
==========

Crohn\'s disease (CD) is a chronic-relapsing inflammatory bowel disease (IBD) that can affect the entire gastrointestinal tract. The incidence rate varies from 1 to 20 cases per 10^5^people per year and is still rising in some countries \[[@B1]\]. Although the aetiology of CD remains elusive to date, it is widely accepted that several factors are involved in the onset or perpetuation of the disease. These factors include genetic and immunologic features that confer host susceptibility, and external or environmental factors such as microorganisms and lifestyle \[[@B2],[@B3]\]. Environmental factors play an important role because there is a low concordance between identical twins, both for CD and ulcerative colitis (UC) \[[@B4]\]. The involvement of microbes in the onset or perpetuation of inflammation has been extensively studied \[[@B5]-[@B10]\]. To date, some pathogens have been proposed as causative agents. In particular, adherent-invasive *E. coli*(AIEC) is increasing in relevance because it has been reported to be more prevalent in CD patients than in controls in several countries (France \[[@B11]\], United Kingdom \[[@B12]\], USA \[[@B13],[@B14]\], and Spain \[[@B15]\]). AIEC strains have the ability to adhere to and to invade intestinal epithelial cells *in vitro*as well as to survive and replicate within macrophages without inducing host-cell death and promoting tumour necrosis factor (TNF) α release. No unique genetic sequences have been described for AIEC, nor have specific genes of diarrhoeagenic pathovars been detected yet for AIEC, but they do carry many virulence-associated genes characteristic of extraintestinal pathogenic *E. coli*(ExPEC) \[[@B13],[@B15],[@B16]\]. For that reason, AIEC pathovar has been speculated to be closely related to ExPEC pathovar.

In a previous work, we observed that some CD patients showed a high diversity of AIEC subtypes associated to their intestinal mucosa \[[@B15]\]. In a given patient, we could detect up to 8 different clones as assessed by pulsed field gel electrophoresis. On the other hand, AIEC abundance, richness and diversity were lower in non-IBD controls. We hypothesized that the higher diversification of clones could be explained by a long-term colonization of AIEC in CD. Biofilm formation can be a way to persistently colonize the intestinal mucosa \[[@B17]\], as has been reported for commensal microbiota in healthy subjects \[[@B18]\]. Moreover, for certain organisms such as the species belonging to the uropathogenic *E. coli*pathovar (UPEC) - which form intracellular biofilms \[[@B19]\] - and to the enteroaggregative pathogenic *E. coli*pathovar (EAEC) - which form thick biofilms that adhere to the apical side of enterocytes \[[@B20]\]-, active biofilm formation is feature of their pathogenesis. For that reason, the primarily aim of this work was to determine the biofilm formation capacity of AIEC strains and non-AIEC strains, both isolated from the intestinal mucosa.

We herein report a new phenotypic feature of the recently described AIEC pathovar which is the ability to form biofilms *in vitro*. In addition, we illustrate those seropathotypes and phylotypes more frequently found amongst biofilm producers.

Results
=======

AIEC strains are stronger biofilm producers than non-AIEC strains isolated from the intestinal mucosa
-----------------------------------------------------------------------------------------------------

The present study involved a collection of 65 *E. coli*strains, 27 of which (41.5%) were classified as AIEC by their ability to adhere to and invade intestinal epithelial cells, and to survive and replicate within macrophages, as previously described \[[@B11]\] (Table [1](#T1){ref-type="table"}).

###### 

Phenotypic and genotypic characteristics of the bacterial strains used in this study.

  Id Strain   Origin   Serotype    Phylo.   Virulence gene carriage
  ----------- -------- ----------- -------- -----------------------------------------------------------
  AIEC19      C        ONT: H-     A        *iucD, fimH, fimAv*~*MT*78~
                                            
  AIEC07      C        O22: H7     B1       *papC, iucD, fimH*
                                            
  AIEC04      C        O6: HNT     B2       *papC, sfa/focDE, iucD, hlyA, cnf1, fimH, fimAv*~*MT*78~
                                            
  AIEC10      C        O159: H34   A        *fimH*
                                            
  AIEC06      C        O6: H5      B2       *papC, sfa/focDE, hlyA, cnf1, fimH, cdtB*
                                            
  AIEC08      C        O25:H4      B2       *papC, iucD, ibeA, fimH, cdtB*
                                            
  AIEC25      CD       O6: H31     B2       *papC, hlyA, cnf1, fimH*
                                            
  AIEC21      CD       O6: H1      B2       *papC, iucD, hlyA, cnf1, fimH*
                                            
  AIEC12      CD       O26: H-     B2       *papC, afa/draBC, iucD, fimH*
                                            
  AIEC20      CD       O11: H18    D        *papC, afa/draBC, iucD, fimH*
                                            
  AIEC17      CD       ONT: HNT    D        *neuC, ibeA, fimH*
                                            
  AIEC05      CD       O1: H-      B2       *papC, neuC, fimH*
                                            
  AIEC02      CD       O8: H21     B2       *papC, neuC, fimH*
                                            
  AIEC01      CD       O6: H1      B2       *sfa/focDE, iucD, fimH*
                                            
  AIEC09      CD       ONT: H-     B2       *papC, sfa/focDE, iucD, hlyA, cnf1, fimH, fimAv*~*MT*78~
                                            
  AIEC24      CD       ONT: H-     A        *iucD, fimH, fimAv*~*MT*78~
                                            
  AIEC23      CD       O5: HNT     A        *fimH*
                                            
  AIEC11      CD       O22: H1     B2       *afa/draBC, iucD, fimH*
                                            
  AIEC15-1    CD       O22: H1     B2       *fimH*
                                            
  AIEC14-1    CD       O22: H1     B2       *fimH*
                                            
  AIEC16-2    CD       O22: H1     B2       *fimH*
                                            
  LF82        CD       O83: H1     B2       *ibeA, fimH, fimAv*~*MT*78~
                                            
  AIEC13      UC       O25: H4     B2       *papC, iucD, hlyA, cnf1, ibeA, fimH, cdtB*
                                            
  PP16        Sepsis   O83: H1     B2       *ibeA, fimH, fimAv*~*MT*78~
                                            
  FV7563      UTI      O25: H4     B2       *afa/draBC, iucD, fimH*
                                            
  OL96A       UTI      O6: H1      B2       *papC, sfa/focDE, iucD, hlyA, cnf1, fimH*
                                            
  PP215       Sepsis   O6: H1      B2       *papC, sfa/focDE, iucD, hlyA, cnf1, fimH*
                                            
  ECG-046     C        ONT: H29    B1       *iucD*, pCDV432
                                            
  ECG-060     C        O102: H6    D        *papC, iucD, fimH*
                                            
  ECG-037     C        O1: H-      D        *papC, neuC, iucD, fimH, fimAv*~*MT*78~
                                            
  ECG-016     C        O55: H-     A        *neuC, iucD, fimH*
                                            
  ECG-017     C        O22: H18    B2       *sfa/focDE, fimH*
                                            
  ECG-022     C        O15: H-     A        *afa/draBC, neuC, iucD, fimH*
                                            
  ECG-043     C        O83: H1     B2       *ibeA, fimH, fimAv*~*MT*78~
                                            
  ECG-041     C        O2: H-      B2       *papC, sfa/focDE, iucD, hlyA, cnf1, fimH, cdtB*
                                            
  ECG-012     C        O18: H1     B2       *papC, sfa/focDE, iucD, hlyA, cnf1, fimH*
                                            
  ECG-025     C        O6: H31     B2       *papC, hlyA, cnf1, fimH*
                                            
  ECG-049     C        O15: H16    B2       *papC, iucD, fimH*
                                            
  ECG-031     C        O161: H4    D        *iucD, fimH*
                                            
  ECG-023     C        ONT: H-     At       *iucD, fimH, fimAv*~*MT*78~
                                            
  ECG-054     C        O14: H-     D        *papC, iucD, fimH*
                                            
  ECG-008     C        O14: H7     B2       *papC, iucD, ibeA, fimH, fimAv*~*MT*78~
                                            
  ECG-004     C        O22: H7     B1       *fimH*
                                            
  ECG-013     C        O18: H1     B2       *papC, sfa/focDE, iucD, hlyA, cnf1, fimH*
                                            
  ECG-055     C        O17: H18    D        *papC, iucD, fimH*
                                            
  ECG-024     C        O174: H-    B1       *fimH*
                                            
  ECG-064     CD       O166: H21   B1       *fimH*
                                            
  ECG-042     CD       O7: H6      B2       *fimH, fimAv*~*MT*78~
                                            
  ECG-001     CD       O6: H31     B2       *papC, hlyA, cnf1, fimH*
                                            
  ECG-005     CD       O4: H5      B2       *papC, sfa/focDE, hlyA, cnf1, fimH*
                                            
  ECG-065     CD       O141: H-    A        *fimH, fimAv*~*MT*78~
                                            
  ECG-047     CD       O119: H21   D        *iucD, fimH*
                                            
  ECG-019     CD       ONT: H-     A        
                                            
  ECG-018     CD       ONT: H-     A        *iucD*
                                            
  ECG-002     CD       O175: H-    B1       *fimH*
                                            
  ECG-034     CD       O127: H28   D        *iucD, fimH*
                                            
  ECG-021     CD       O54: H21    B1       *fimH*
                                            
  ECG-063     CD       ONT: H21    B1       *fimH*
                                            
  ECG-056     CD       ONT: H18    D        *papC, afa/draBC, iucD, fimH*
                                            
  ECG-057     CD       O11: H18    D        *papC, afa/draBC, iucD, fimH*
                                            
  ECG-053     CD       O11: H-     D        *papC, afa/draBC, iucD, fimH*
                                            
  ECG-059     CD       ONT: H18    D        *papC, iucD, fimH*
                                            
  ECG-026     CD       O1: H-      B2       *papC, neuC, ibeA, fimH, fimAv*~*MT*78~
                                            
  ECG-015     CD       O2: H6      B2       *papC, sfa/focDE, neuC, hlyA, cnf1, fimH*
                                            
  ECG-009     CD       O83: H1     B2       *sfa/focDE, neuC, iucD, ibeA, fimH, fimAv*~*MT*78~,*cdtB*

Abbreviators: CD: Crohn\'s disease; UC: ulcerative colitis; C: non-IBD control, UTI: urinary tract infection; ONT: serogroup non-typeable; HNT: flagellar antigen non-typeable; H-: nonmotile strain; Phylo.: Phylogroup; At: Atypical.

Within the category of weak biofilm producers, 74.4% of strains were non-AIEC, whereas 65.4% of moderate to strong biofilm producers were AIEC (P = 0.002). Amongst these AIEC strains, 22.2% were strong biofilm producers, and 40.7% were moderate biofilm producers (Table [2](#T2){ref-type="table"}). Similar results were obtained when SBF index values were compared. As shown in Figure [1](#F1){ref-type="fig"}, the mean SBF index was higher in AIEC strains than in non-AIEC (SBF~AIEC~= 0.65 ± 0.53; SBF~NON-AIEC~= 0.36 ± 0.36; P = 0.012).

###### 

AIEC phenotype and category of biofilm formation ability of the strains.

  Id Strain   AIEC   I_ADH (mean ± SD)   I_INV (mean ± SD)   I_REPL (mean ± SD)   SBF (mean ± SD)   BFC                                  
  ----------- ------ ------------------- ------------------- -------------------- ----------------- -------- --------- ------- --------- ---
  AIEC19      \+     2.40                ± 0.65              0.111                ± 0.016           1568.1   ± 1726    0.053   ± 0.019   W
                                                                                                                                         
  AIEC07      \+     20.00               ± 13.50             0.565                ± 0.392           1692.6   ± 296.8   2.391   ± 0.317   S
                                                                                                                                         
  AIEC04      \+     21.50               ± 9.00              0.320                ± 0.016           584.7    ± 418.5   0.772   ± 0.132   M
                                                                                                                                         
  AIEC10      \+     6.00                ± 0.98              0.226                ± 0.192           1413.7   ± 51.4    0.610   ± 0.175   M
                                                                                                                                         
  AIEC06      \+     10.25               ± 3.25              0.177                ± 0.019           1717.7   ± 307.9   1.212   ± 0.233   S
                                                                                                                                         
  AIEC08      \+     1.13                ± 0.18              0.172                ± 0.066           104.8    ± 49.7    0.397   ± 0.133   W
                                                                                                                                         
  AIEC25      \+     2.75                ± 1.33              0.482                ± 0.129           775.9    ± 128.3   0.437   ± 0.129   W
                                                                                                                                         
  AIEC21      \+     17.00               ± 7.75              0.109                ± 0.013           1297.1   ± 625.2   0.558   ± 0.205   M
                                                                                                                                         
  AIEC12      \+     22.25               ± 4.00              0.142                ± 0.017           193.7    ± 55.9    0.125   ± 0.052   W
                                                                                                                                         
  AIEC20      \+     14.25               ± 6.25              0.125                ± 0.098           343.9    ± 244.6   0.284   ± 0.116   W
                                                                                                                                         
  AIEC17      \+     21.75               ± 17.50             0.266                ± 0.055           1053.0   ± 75.0    0.840   ± 0.286   M
                                                                                                                                         
  AIEC05      \+     9.50                ± 2.25              0.202                ± 0.042           704.9    ± 714.0   0.181   ± 0.072   W
                                                                                                                                         
  AIEC02      \+     0.85                ± 1.03              0.802                ± 0.035           2187.8   ± 4.8     0.106   ± 0.035   W
                                                                                                                                         
  AIEC01      \+     16.00               ± 9.25              0.284                ± 0.106           1566.7   ± 1060    0.700   ± 0.177   M
                                                                                                                                         
  AIEC09      \+     5.25                ± 4.00              0.216                ± 0.010           2562.3   ± 240.6   0.068   ± 0.035   W
                                                                                                                                         
  AIEC24      \+     1.98                ± 1.40              0.309                ± 0.138           1625.6   ± 115.6   0.076   ± 0.044   W
                                                                                                                                         
  AIEC23      \+     9.75                ± 0.70              0.568                ± 0.148           2362.1   ± 250.2   0.300   ± 0.093   W
                                                                                                                                         
  AIEC11      \+     0.83                ± 0.19              2.125                ± 1.164           739.4    ± 477.4   0.537   ± 0.129   M
                                                                                                                                         
  AIEC15-1    \+     25.00               ± 15.75             2.261                ± 1.349           776.9    ± 304.8   1.090   ± 0.407   S
                                                                                                                                         
  AIEC14-1    \+     4.25                ± 3.50              0.508                ± 0.081           847.9    ± 512.8   0.654   ± 0.153   M
                                                                                                                                         
  AIEC16-2    \+     10.00               ± 1.425             0.305                ± 0.159           659.7    ± 437.0   0.502   ± 0.134   M
                                                                                                                                         
  LF82        \+     25.00               ± 5.25              2.261                ± 0.011           776.9    ± 252.4   1.641   ± 0.326   S
                                                                                                                                         
  AIEC13      \+     1.20                ± 4.25              0.104                ± 0.000           1045.9   ± 181.6   0.772   ± 0.211   M
                                                                                                                                         
  PP16        \+     8.00                ± 0.98              1.400                ± 0.081           225.9    ± 541.2   1.012   ± 0.268   S
                                                                                                                                         
  FV7563      \+     6.75                ± 6.00              0.129                ± 0.072           470.0    ± 264.0   0.518   ± 0.226   M
                                                                                                                                         
  OL96A       \+     5.25                ± 5.00              0.388                ± 0.159           457.5    ± 259.3   1.208   ± 0.202   S
                                                                                                                                         
  PP215       \+     0.83                ± 0.60              0.453                ± 0.350           1425.4   ± 229.4   0.546   ± 0.139   M
                                                                                                                                         
  ECG-046     \-     \-                                      \< 0.1                                 \-                 0.004   ± 0.010   W
                                                                                                                                         
  ECG-060     \-     \-                                      \< 0.1                                 \-                 0.127   ± 0.041   W
                                                                                                                                         
  ECG-037     \-     \-                                      \< 0.1                                 \-                 0.042   ± 0.024   W
                                                                                                                                         
  ECG-016     \-     \-                                      \< 0.1                                 \-                 0.134   ± 0.085   W
                                                                                                                                         
  ECG-017     \-     \-                                      \< 0.1                                 \-                 1.074   ± 0.286   S
                                                                                                                                         
  ECG-022     \-     \-                                      \< 0.1                                 \-                 0.143   ± 0.090   W
                                                                                                                                         
  ECG-043     \-     \-                                      \< 0.1                                 \-                 1.187   ± 0.511   S
                                                                                                                                         
  ECG-041     \-     \-                                      \< 0.1                                 \-                 0.301   ± 0.123   W
                                                                                                                                         
  ECG-012     \-     \-                                      \< 0.1                                 \-                 0.741   ± 0.259   M
                                                                                                                                         
  ECG-025     \-     \-                                      \< 0.1                                 \-                 0.154   ± 0.043   W
                                                                                                                                         
  ECG-049     \-     \-                                      \< 0.1                                 \-                 0.384   ± 0.160   W
                                                                                                                                         
  ECG-031     \-     \-                                      \< 0.1                                 \-                 0.067   ± 0.024   W
                                                                                                                                         
  ECG-023     \-     0.90                ± 0.65              0.052                ± 0.003           \-                 0.038   ± 0.020   W
                                                                                                                                         
  ECG-054     \-     \-                                      \< 0.1                                 \-                 0.209   ± 0.128   W
                                                                                                                                         
  ECG-008     \-     \-                                      \< 0.1                                 \-                 0.817   ± 0.288   M
                                                                                                                                         
  ECG-004     \-     \-                                      \< 0.1                                 \-                 1.113   ± 0.234   S
                                                                                                                                         
  ECG-013     \-     \-                                      \< 0.1                                 \-                 0.516   ± 0.332   M
                                                                                                                                         
  ECG-055     \-     \-                                      \< 0.1                                 \-                 0.108   ± 0.033   W
                                                                                                                                         
  ECG-024     \-     \-                                      \< 0.1                                 \-                 0.037   ± 0.016   W
                                                                                                                                         
  ECG-064     \-     \-                                      \< 0.1                                 \-                 0.553   ± 0.171   M
                                                                                                                                         
  ECG-042     \-     \-                                      \< 0.1                                 \-                 0.348   ± 0.147   W
                                                                                                                                         
  ECG-001     \-     \-                                      \< 0.1                                 \-                 0.299   ± 0.106   W
                                                                                                                                         
  ECG-005     \-     \-                                      \< 0.1                                 \-                 0.404   ± 0.103   W
                                                                                                                                         
  ECG-065     \-     \-                                      0.061                ± 0.070           \-                 0.026   ± 0.022   W
                                                                                                                                         
  ECG-047     \-     1.93                ± 1.95              0.259                ± 0.084           \-                 0.007   ± 0.016   W
                                                                                                                                         
  ECG-019     \-     \-                                      \< 0.1                                 \-                 0.439   ± 0.057   W
                                                                                                                                         
  ECG-018     \-     \-                                      \< 0.1                                 \-                 0.058   ± 0.042   W
                                                                                                                                         
  ECG-002     \-     \-                                      \< 0.1                                 \-                 0.039   ± 0.023   W
                                                                                                                                         
  ECG-034     \-     \-                                      \< 0.1                                 \-                 0.293   ± 0.101   W
                                                                                                                                         
  ECG-021     \-     6.00                ± 4.00              0.033                ± 0.011           \-                 0.311   ± 0.117   W
                                                                                                                                         
  ECG-063     \-     \-                                      \< 0.1                                 \-                 0.195   ± 0.064   W
                                                                                                                                         
  ECG-056     \-     \-                                      \< 0.1                                 \-                 0.124   ± 0.047   W
                                                                                                                                         
  ECG-057     \-     11.75               ± 7.25              0.013                ± 0.011           \-                 0.241   ± 0.094   W
                                                                                                                                         
  ECG-053     \-     \-                                      \< 0.1                                 \-                 0.262   ± 0.083   W
                                                                                                                                         
  ECG-059     \-     \-                                      \< 0.1                                 \-                 0.200   ± 0.137   W
                                                                                                                                         
  ECG-026     \-     \-                                      \< 0.1                                 \-                 0.418   ± 0.189   W
                                                                                                                                         
  ECG-015     \-     5.25                ± 2.75              0.038                ± 0.004           \-                 1.035   ± 0.219   S
                                                                                                                                         
  ECG-009     \-     \-                                      \< 0.1                                 \-                 1.346   ± 0.205   S

Adhesion, invasion, intra-macrophage replication, and biofilm formation indices are specified. Abbreviators: AIEC: AIEC phenotype (+: strains that adhere to and invade Intestine-407 cells and that were able to survive and/or replicate within J774 macrophages *in vitro*); I_ADH: adhesion index; I_INV: invasion index; I_REPL: replication index; SBF: specific biofilm formation index; BFC: Biofilm formation category; W: weak biofilm producer; M: moderate biofilm producer; and S: strong biofilm producer.

![**Mean specific biofilm formation (SBF) index of AIEC and mucosa-associated non-AIEC strains**. The mean SBF index was higher for AIEC than for non-AIEC strains, as corroborated by one-way ANOVA (P = 0.012).](1471-2180-9-202-1){#F1}

Interestingly, higher adhesion indices from both AIEC and non-AIEC strains correlated with higher SBF indices (P = 0.009). Moreover, the correlation was even stronger between the invasion and biofilm formation capacities of AIEC strains (P = 0.003). No correlation was observed with the ability of AIEC strains to survive and replicate within macrophages (Figure [2](#F2){ref-type="fig"}).

![**Correlations between biofilm formation and the adhesion, invasion, and intra-macrophage replication abilities of both AIEC and non-AIEC strains**. Adhesion and invasion indices correlated positively with biofilm formation capacity, whereas intra-macrophage survival and replication did not. Adhesion index was calculated as: I_ADH = attached bacterial cells/intestinal cell; invasion index as: I_INV(%) = (intracellular bacteria/4×10^6^bacteria inoculated) × 100; and replication index as: I_REPL = (cfu ml^-1^at 24 h/cfu ml^-1^at 1 h)× 100.](1471-2180-9-202-2){#F2}

Nonmotile strains were unable to form biofilms and, amongst motile strains, those with H1 flagellar type showed the highest biofilm formation indices
-----------------------------------------------------------------------------------------------------------------------------------------------------

An additional factor that was associated with biofilm formation was the motility of the strains. Regardless of adhesion and invasion abilities, motile strains showed higher SBF indices than nonmotile strains (SBF~MOTILE~= 0.61 ± 0.48, SBF~NONMOTILE~= 0.14 ± 0.13; P \< 0.001). All strains producing moderate-strong biofilms were motile, whereas strains classified as weak biofilm producers were heterogeneous in their motility capacities. In concordance, the isogenic mutant LF82-Δ*fliC*which is nonmotile, non-flagellated and express only few type 1 pili, did not display the ability to form biofilms (SBF = 0,393 ± 0,084) in contrast to LF82 wild type (SBF = 1.641 ± 0.326).

Moreover, SBF indices were specifically higher for the H1 serotype as shown in Figure [3](#F3){ref-type="fig"}. All H1 serotypes were moderate-strong biofilm producers. In contrast, only 12 out of 33 (36.4%) of strains with other H types were classified within this category (Table [3](#T3){ref-type="table"}).

###### 

Frequency of strains according to their motility capacity and flagellar antigen type within biofilm producers and non-producers.

  ------------------------------------------------------------------------------------------------------------------
                        Biofilm formation category                                    
  --------------------- ---------------------------- -------------- ------- --------- ------------------------------
                        **Moderate-Strong**\         **Weak**\                        
                        **(N = 26)**                 **(N = 39)**                     

                                                                                      

  **Motility/H type**   **N**                        **(%)**        **N**   **(%)**   **P**

                                                                                      

  H- (N = 18)           0                            \(0\)          18      (46.2)    \< 0.001^*a*^, 0.003^*b*^

                                                                                      

  H1 (N = 14)           14                           (53.8)         0       \(0\)     \< 0.001^*a*^, \< 0.001^*c*^

                                                                                      

  Hx (N = 33)           12                           (46.2)         21      (53.8)    \< 0.001^*c*^, 0.003^*b*^
  ------------------------------------------------------------------------------------------------------------------

Abbreviators: H-: nonmotile strains; H1: motile and H1 flagellar type; Hx: motile and any flagellar type except H1.^*a*^significance between H- and H1; ^*b*^significance between H- and Hx; ^*c*^significance between H1 and Hx.

![**Mean SBF index of motile and nonmotile strains irrespectively of their AIEC phenotype**. SBF indices were higher in motile strains, especially H1 serotypes, than nonmotile strains. H-: nonmotile strains; H1: motile and H1 flagellar type; Hx: motile and any flagellar type except for H1.](1471-2180-9-202-3){#F3}

To determine whether motility and AIEC-like phenotype were intrinsically related factors, the frequency of motile and nonmotile strains within AIEC and non-AIEC strains was calculated. Although the majority of AIEC strains were motile (81.5%), no significant differences were observed in comparison to non-AIEC strains (65.8%). Moreover, no interaction among these factors was detected by applying a factorial ANOVA. Therefore, motility and adherence/invasion capacity were independent factors associated with biofilm formation.

Serogroups associated with higher biofilm producing abilities
-------------------------------------------------------------

As shown in Figure [4](#F4){ref-type="fig"}, O83, followed by O22, showed the highest mean SBF indices. Regardless the AIEC phenotype and origin of the strains (intestinal or extraintestinal and non-IBD or CD associated), all the strains of O22 and O83 serogroup were found to be moderate-strong biofilm producers.

![**Mean SBF index of the strains classified by their serogroup**. White bars: Serogroups with mean SBF that falls into \'weak\' biofilm formation category. Grey bars: Serogroups with mean SBF that falls into \'moderate\' biofilm formation category. Black bars: Serogroups with mean SBF that falls into \'strong\' biofilm formation category. The serotype of those *E. coli*strains that showed different biofilm formation category than the mean SBF for the serogroup is specified: 1: Only AIEC17 (ONT:HNT) strain was classified as \'moderate\' biofilm producer (M). 2: Nonmotile ECG-041 (O2:H-) strain was classified as \'weak\' biofilm producer (W). 3: Three strains with O6:H31 serotype were classified as \'weak\' biofilm producers, whereas strains with O6:H1, O6:H5 and O6:HNT serotypes were \'moderate\' or \'strong\' biofilm producers. 4: Nonmotile ECG-054 (O14:H-) was \'weak\' biofilm producer (W). 5: Three strains were \'moderate\' (O22:H1) and 4 strains \'strong\' (O22:H1, O22:H7, and O22:H18) biofilm producers. 6: AIEC08 (O25:H4) was classified as \'weak\' biofilm producer.](1471-2180-9-202-4){#F4}

Other serogroups with mean SBF that fell into the \'moderate\' category were: O2, O6, O14, O18, O25, O159, and O166. However, some strains that were unable to form biofilms were detected amongst these serogroups. For some serogroups such as O2 and O14 those strains classified as weak biofilm producers were particularly those nonmotile O2/O14 strains. In turn, strains with weak to strong biofilm formation abilities amongst the O6 strains belonged to a certain serotype (O6:H31) and this serotype was not present amongst the categories \'moderate\' or \'strong\' biofilm producers. Nevertheless, very few strains have been analyzed for some of these serogroups (O2, O14, O18, O25, O159, and O166) due to the nature of the strains isolated from the intestinal mucosa, thus no robust conclusions can be extracted for them.

Distribution of virulence-associated genes and phylogroups within biofilm producers
-----------------------------------------------------------------------------------

Of the 65 *E. coli*strains used in this study, 45 (69.2%) harboured more than two virulence-associated genes in addition to *fimH*; thus, these strains are considered an extraintestinal pathogenic *E. coli*according to the definition of Johnson *et al*\[[@B21]\]. Virulence-associated gene distribution was similar between biofilm producers (moderate-strong) and non-biofilm producers (weak), with the exception of adherence factor *sfa/focDE*(S or F1C fimbriae) and the invasion-associated gene *ibeA*(Table [4](#T4){ref-type="table"}), which were more prevalent in biofilm-forming strains (P = 0.003 and P = 0.017, respectively).

###### 

Comparison of virulence gene prevalence and phylogroup between weak and moderate-strong biofilm producers.

  ---------------------------------------------------------------------------------------------------------------------------------------------
                                                                            Biofilm formation category                               
  ----------------------------------- -------------- ---------------------- ---------------------------- --------- ------- --------- ----------
                                      **Total**\     **Moderate-Strong**\   **Weak**\                    **P**                       
                                      **(N = 65)**   **(N = 26)**           **(N = 39)**                                             

                                                                                                                                     

  **Virulence gene**                  **N**          **(%)**                **N**                        **(%)**   **N**   **(%)**   

                                                                                                                                     

  Adhesin-encoding genes                                                                                                             

                                                                                                                                     

  *papC*                              32             (49.2)                 11                           (42.3)    21      (53.8)    0.255

                                                                                                                                     

  *sfa/focDE*                         13             (20.0)                 10                           (38.5)    3       (7.7)     0.003

                                                                                                                                     

  *afa/draBC*                         8              (12.3)                 2                            (7.7)     6       (15.4)    0.301

                                                                                                                                     

  *fimH*                              62             (95.4)                 26                           \(100\)   36      (92.3)    0.209

                                                                                                                                     

  *fimAv*~*MT*78~                     14             (21.5)                 6                            (23.1)    8       (20.5)    0.520

                                                                                                                                     

  Protectin/invasion-encoding genes                                                                                                  

                                                                                                                                     

  *ibeA*                              9              (13.8)                 7                            (26.9)    2       (5.1)     0.017

                                                                                                                                     

  K1 *neuC*                           9              (13.8)                 3                            (11.5)    6       (15.4)    0.478

                                                                                                                                     

  Siderophore-related genes                                                                                                          

                                                                                                                                     

  *iucD*                              37             (56.9)                 13                           (50.0)    24      (61.5)    0.253

                                                                                                                                     

  Toxin-encoding genes                                                                                                               

                                                                                                                                     

  *hlyA*                              15             (23.1)                 9                            (34.6)    6       (15.4)    0.067

                                                                                                                                     

  *cnf1*                              15             (23.1)                 9                            (34.6)    6       (15.4)    0.067

                                                                                                                                     

  *cdtB*                              5              (7.7)                  3                            (11.5)    2       (5.1)     0.312

                                                                                                                                     

  Phylogroup                                                                                                                         

                                                                                                                                     

  A                                   9              (13.8)                 1                            (3.8)     8       (21.1)    0.052

                                                                                                                                     

  B1                                  8              (12.3)                 3                            (11.5)    5       (13.2)    0.583

                                                                                                                                     

  B2                                  34             (52.3)                 21                           (80.8)    13      (34.2)    \< 0.001

                                                                                                                                     

  D                                   13             (20.0)                 1                            (3.8)     12      (31.6)    0.006
  ---------------------------------------------------------------------------------------------------------------------------------------------

Although the *E. coli*collection studied was mainly composed of B2 (52.3%) and D (20%) phylotypes, significant differences were observed between the two categories of biofilm producers. As shown in Table [4](#T4){ref-type="table"}, the B2 phylogroup was more frequent in moderate-strong biofilm forming strains (80.8% vs. 34.2%; P \< 0.001), whereas A and D phylogroups were more frequent within weak biofilm producers.

Discussion
==========

In this work, we describe the biofilm formation capacity of a recently described pathovar, adherent-invasive *E. coli*(AIEC), which is associated with Crohn\'s disease. The main result was that AIEC strains have stronger biofilm formation abilities than other *E. coli*strains isolated from the intestinal mucosa (non-AIEC). The latter share genotypic and phenotypic traits with AIEC \[[@B15]\] but lack the properties described for the pathovar: (i) adhesion to and invasion of intestinal epithelial cells *in vitro*, (ii) survival and replication capacity within macrophages without causing host-cell death, and (iii) induction of TNF-α release \[[@B11]\]. We also analyzed the relationship between biofilm formation, AIEC phenotype, serotype, and phylogroup, and the presence of virulence-associated genes.

As observed by other authors \[[@B22],[@B23]\], motility was a crucial factor for biofilm formation because none of the nonmotile strains were able to form biofilms (Table [3](#T3){ref-type="table"}). This observation was further supported by the experiments performed with the isogenic mutant LF82-Δ*fliC*. Moreover, all 14 strains with H1 flagellar antigen were moderate-strong biofilm producers, in contrast to 46.2% of motile non-H1 types. Therefore, H1 flagellar antigen conferred, either directly or indirectly, an advantageous trait to form biofilms. Although motility was a necessary requirement for biofilm formation, it was not sufficient; 21 out of 47 motile strains were weak biofilm producers, indicating that additional factors are needed. In addition, strains with O2, O6, O14, O18, O22, O25, O83, O159 and O166 serogroups were found amongst the biofilm producers, in accordance with previous studies \[[@B24],[@B25]\]. Interestingly, the highest mean SBFs index was achieved by four strains that belonged to the O83 serogroup, in particular the O83:H1 serotype, being all the strains classified as strong biofilm producers. This group included two AIEC strains (AIEC reference strain LF82 \[[@B11]\], and the sepsis-associated strain PP16) and two non-AIEC strains (ECG-009 (isolated from two different CD patients) and ECG-043 (isolated from one non-IBD control) \[[@B15]\].

Some associations between biofilm-formation potential and some virulence-associated genes have been already described \[[@B24],[@B26]-[@B32]\]. In agreement with previous studies \[[@B25]\], the adhesin-coding gene *sfa/foc*DE was more frequently detected amongst biofilm producers. In addition, the gene *ibeA*, required for invasion in meningitis/sepsis-associated *E. coli*(MNEC) \[[@B33],[@B34]\], was more prevalent amongst strong biofilm producers. Interestingly, *ibeA*, in conjunction with *fimH*and *fimAv*~*MT*78~, are virulence factors present in AIEC strain LF82 \[[@B16],[@B35]\].

Phylogenetic analyses have shown that *E. coli*strains fall into four main phylogenetic groups (A, B1, B2, and D) and that virulent ExPEC strains mainly belong to group B2 and, to a lesser extent, group D, whereas most commensal strains belong to group A \[[@B33],[@B36]\]. Although B2 was the most abundant phylotype within the *E. coli*collection, B2 phylotypes were significantly more prevalent amongst moderate-strong biofilm producers than weak biofilm producers (P \< 0.001), which were enriched in A and D phylotypes (P = 0.052 and P = 0.006 respectively). Of note, B2+D phylotypes are also more prevalent amongst *E. coli*strains from patients with CD or ulcerative colitis than in non-IBD controls \[[@B37]\].

The positive correlation between the levels of adhesion and invasion and the higher SBF indices lead to postulate that the machinery implicated to achieve the \"AIEC phenotype\" could share some factors necessary for biofilm formation, such as type 1 pili and flagella. Another possibility is that both processes could be related to a coordinated expression, for instance, by the EnvZ/OmpR regulatory system. Rohlion *et al*\[[@B38]\] recently proposed a model in which OmpC, a porin regulated by EnvZ/OmpR, has been implicated in the adherence-invasiveness of AIEC, and this system is also known to play an important role in biofilm formation \[[@B39]\]. The biofilm formation could also be dependent on the cyclic di-GMP concentration which was recently reported to regulate the expression of type 1 pili and flagella in AIEC reference strain LF82 \[[@B40]\].

Biofilms in the human gut are thought to play an agonistic role with the host \[[@B18]\], being necessary to achieve an homeostatic situation and appropriate gut physiology. Nevertheless, previous studies have highlighted the increased biofilm formation in patients with CD with respect to control subjects \[[@B41]\]. Moreover, the composition of the mucosa-associated microbiota is altered with respect to that of non-IBD controls \[[@B42]\]. It is widely accepted that the intestinal microbiota is essential to elicit the inflammation; however, the specific role of intestinal biofilms in CD is still uncertain. Changes in the composition and abundance of mucosa-associated biofilms have been proposed either to play a role in the onset or perpetuation of CD \[[@B41],[@B43]-[@B45]\] or to be a consequence of the defective immune regulation in CD patients \[[@B18],[@B46],[@B47]\]. Because we have analyzed the biofilm formation capacity of a collection of AIEC and non-AIEC strains using an *in vitro*method we can deduce that the ability of AIEC to form biofilms is irrespective of host factors. However, *in vivo*experiments would give interesting insights into the pathogenesis of AIEC in CD. Biofilm formation of AIEC in human gut, if confirmed, would confer to the pathovar an advantage for colonization of the intestine. Consequently, given the pathogenic behavior of AIEC, a more stable colonization would increase their probability of invading the intestinal epithelium and further trigger mucosal inflammation and, possibly, granuloma formation. In this sense, and speculatively, biofilm formation could contribute to AIEC pathogenesis.

Conclusion
==========

A novel phenotypic trait of AIEC pathovar was described in this work. Biofilm production ability of AIEC strains could be an additional trait involved in their pathogenesis. Further investigations to detect AIEC specific genetic determinants involved in biofilm formation and to analyze the genetic regulatory processes are essential to fully understand AIEC pathogenesis and elucidate a possible role of AIEC in CD.

Methods
=======

Bacterial strains
-----------------

Amongst the collection of 65 *E. coli*strains, sixty-one (93.8%) were isolated from human intestinal mucosa in previous studies \[[@B15],[@B48]\]. In particular, 35 strains (16 of them were AIEC) came from CD patients, one (which belonged to AIEC pathovar) came from a patient suffering from ulcerative colitis, and 25 (of which 6 were AIEC) came from non-IBD controls. Also included were four additional AIEC strains that came from patients with extraintestinal infection (two with sepsis and two with urinary tract infection \[[@B49],[@B50]\]). AIEC reference strain LF82 and the isogenic mutant LF82-Δ*fliC*were used as controls. Relevant characteristics of the strains that were known prior to this study are compiled in Table [1](#T1){ref-type="table"}.

All procedures were approved by the ethics committee of clinical investigation of the Hospital Josep Trueta of Girona in compliance with the Helsinki declaration.

Biofilm formation assay
-----------------------

Biofilm formation assays were performed using a previously described method \[[@B26]\] with some modifications \[[@B25]\]. Strains were grown overnight in Luria-Bertani broth with 5 g l^-1^of glucose (Sigma-Aldrich, St. Louis, USA) at 35.5°C, then 1/100 dilutions were made in M63 minimal medium (US Biological, Swampscott, USA) supplemented with 8 g l^-1^(0.8%) glucose. Then, 130-*μ*l aliquots were placed in wells of non-cell-treated polystyrene microtiter plates (Greiner Bio-one, Stuttgart, Germany) and incubated overnight at 30°C without shaking. Afterwards, growth optical densities (OD) were read at 630 nm; then the wells were washed once, adhered bacteria were stained with 1% crystal violet solubilised in ethanol, and ODs read at 570 nm. Biofilm measurements were calculated using the formula *SBF = (AB-CW)/G*, in which *SBF*is the specific biofilm formation, *AB*is the OD~570\ nm~of the attached and stained bacteria, *CW*is the OD~570\ nm~of the stained control wells containing only bacteria-free medium (to eliminate unspecific or abiotic OD values), and *G*is the OD~630\ nm~of cell growth in broth \[[@B51],[@B52]\]. For each assay, 16 wells per strain were analyzed, and the assays were performed in triplicate, which resulted in a total of 48 wells per each tested strain and control. The degree of biofilm production was classified in three categories: weak (SBF ≤ 0.5), moderate (0.5 \> SBF ≤ 1), and strong (SBF \> 1).

Adhesion and invasion assays in epithelial cells Intestine-407
--------------------------------------------------------------

The epithelial cell line Intestine-407 was used for adhesion and invasion assays (ATCC accession number CCL-6™). Cell culture was performed as described previously \[[@B48]\]. To quantify adhesion and invasion properties, a gentamicin protection assay were performed as previously described \[[@B48]\]. Briefly, 24-well plates containing 4×10^5^cells/well incubated for 20 hours were infected at a multiplicity of infection of 10. Duplicated plates, for adhesion and invasion assays were incubated for 3 hours at 37°C. For bacterial adhesion assays, cell monolayers were washed 5 times with PBS and lysed with 1% Triton X-100. Adhered bacteria were quantified by plating them in nutrient agar. Plating was performed in a maximum period of 30 minutes to avoid bacterial lysis by Triton X-100. Adherence ability (I_ADH) was determined as the mean number of bacteria per cell. For bacterial invasion assays, monolayers were washed twice with PBS after 3 hours of infection, and fresh cell culture medium containing 100 μg ml^-1^of gentamicin was added for 1 hour to kill extracellular bacteria. After cell lysis with 1% Triton X-100, the number of intracellular bacteria was also determined by plating. All assays were performed in triplicate. The invasive ability was expressed as the percentage of intracellular *E. coli*compared with the initial inoculum, taken as 100%: I_INV (%) = (intracellular bacteria/4×10^6^bacteria inoculated) × 100.

Survival and replication in macrophages J774
--------------------------------------------

The macrophage-like J774A.1 cell line (ATCC accession number TIB-67™) was used as a model for *E. coli*survival and replication assays. Cell culture was performed as described previously \[[@B53]\]. *E. coli*isolates with known adherence and invasion properties were then checked for their capability to survive and replicate inside macrophages as previously described \[[@B11]\]. Macrophages were seeded at 2×10^5^cells per well in two 24-well plates and incubated for 20 hours. Once overnight medium was removed and fresh medium was added, bacteria were seeded at a multiplicity of infection of 10. Centrifugation at 900 rpm for 10 minutes, plus an additional incubation at 37°C for 10 minutes, was performed to assist the internalization of bacteria within macrophages. Non-phagocytosed bacteria were killed with gentamicin (20 μg ml^-1^), and intracellular bacteria were quantified as for invasion assays after 1 and 24 hours of infection. All assays were performed in triplicate. Results were expressed as the mean percentage of the number of bacteria recovered after 1 and 24 h post-infection compared with the initial inoculum, taken as 100%: I_REPL (%) = (cfu ml^-1^at 24 h/cfu ml^-1^at 1 h)× 100. Those strains with I_INV \> 0.1 and I_REPL \> 100% were classified as AIEC in this study.

Serotyping
----------

Determination of O and H antigens was carried out using the method previously described by Guinée *et al*. \[[@B54]\]. Strains which failed to achieve motility on semisolid medium were considered nonmotile and designated H-.

Phylotyping and virulence genotyping by PCR
-------------------------------------------

Determination of the major *E. coli*phylogenetic group (A, B1, B2, and D) was performed as previously described by Clermont *et al*\[[@B36]\].

Virulence gene carriage was analyzed as described elsewhere \[[@B25],[@B55]\] using primers specific for 11 genes that encode extraintestinal virulence factors characteristic of ExPEC. These included six adhesins (pyelonephritis-associated pili (*papC*), S and F1C fimbriae (*sfa/focDE*), afimbrial Dr-binding adhesins (*afa/draBC*), type 1 fimbriae (*fimH*), and type 1 variant of avian pathogenic *E. coli*strain MT78 (*fimAv*~MT78~)); three toxins (*hlyA*, *cnf1*, and *cdtB*); and one aerobactin gene (*iucD*). They also included two protectin/invasion-encoding genes that corresponded to K1 *kps*variant (*neuC*) and brain microvascular endothelial cell invasion gene (*ibeA*). Specific genes for diarrhoeagenic *E. coli*pathovars were also screened (*stx1*, *stx2*, *eae*, *bfpA*, *ipaH*, *pCDV432*, *eltA*, and *est*).

Statistical analyses
--------------------

Quantitative parameters, such as SBF, adhesion, and invasion indices were compared by one-way ANOVA. In cases for which the interaction between several factors was of interest, a factorial ANOVA was applied. Correlation between quantitative variables was assessed by Pearson correlation coefficient. Fisher\'s exact test (small contingency tables) or Pearson\'s X^2^tests (frequencies higher than five within cells) were used to measure the significance of frequency values.
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